The approval enables Trinity to transition upstream production from in-house operations to an outsourced model.

Pathway Triangle's King Street Properties confirmed that it has leased manufacturing space in Morrisville. What to know.

Trinity Biotech's patented technology represents a paradigm shift in the global CGM market, projected to exceed $20 billion by 2029DUBLIN, Tuesday, 02 January 2024 12:17 GMT عربي ...

TRINITY BIOTECH PLC - 6-K, Report of foreign issuer: 21.03. Trinity Biotech files to sell 4.29M American Depositary Shares for holders: 14.03. Trinity Biotech receives Nasdaq non-compliance notice ...

DUBLIN - Trinity Biotech plc (NASDAQ:TRIB), a leader in diabetes management solutions currently trading at $0.86 per share, has announced significant enhancements in the performance of its continuous ...

Trinity Biotech’s patented technology represents a paradigm shift in the global CGM market, projected to exceed $20 billion by 2029DUBLIN, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc ...

Trinity Biotech’s patented technology represents a paradigm shift in the global CGM market, projected to exceed $20 billion by 2029. DUBLIN, Ireland, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech ...

TRINITY BIOTECH PLC - 6-K, Report of foreign issuer: 21.03. Trinity Biotech files to sell 4.29M American Depositary Shares for holders: 14.03. Trinity Biotech receives Nasdaq non-compliance notice ...

Trinity Biotech plc has announced encouraging results from its recent pre-pivotal clinical trial of its next-generation continuous glucose monitoring (CGM) system, targeting diabetes management ...

DUBLIN, Ireland, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions ...